Glycosylated Recombinant Human Interleukin-7
Glycosylated Recombinant Human Interleukin-7 Uses, Dosage, Side Effects, Food Interaction and all others data.
Interleukin 7 has been used in trials studying the treatment of Metastatic Breast Cancer.
| Trade Name | Glycosylated Recombinant Human Interleukin-7 |
| Generic | Interleukin-7 |
| Interleukin-7 Other Names | Glycosylated recombinant human interleukin-7, IL-7, Interleukin 7 glycosylated, Interleukin-7 human recombinant, r-hIL-7, Recombinant human interleukin-7, SH-polypeptide-42 |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
How Glycosylated Recombinant Human Interleukin-7 works
Glycosylated Recombinant Human Interleukin-7 human recombinant is a recombinant format of IL-7, a growth factor for T-cells which is shown to help restore and maintain lymphocyte counts, including both CD4+ and CD8+ T-cells, increasing the numbers of functional T-cells. The exact mechanism of action behind this is currently unknown.
Innovators Monograph
You find simplified version here Glycosylated Recombinant Human Interleukin-7
